TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $152,000 | -42.9% | 74,331 | -24.5% | 0.00% | – |
| Q2 2018 | $266,000 | +216.7% | 98,464 | +168.6% | 0.00% | – |
| Q1 2018 | $84,000 | -4.5% | 36,664 | +39.9% | 0.00% | – |
| Q4 2017 | $88,000 | +137.8% | 26,201 | +122.2% | 0.00% | – |
| Q3 2017 | $37,000 | -90.1% | 11,791 | -55.5% | 0.00% | -100.0% |
| Q1 2015 | $372,000 | – | 26,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $18,462,000 | 1.22% |
| WALL STREET ASSOCIATES | 250,000 | $2,442,000 | 0.47% |
| Eventide Asset Management | 403,912 | $3,946,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $4,738,000 | 0.18% |
| J. Goldman & Co LP | 170,000 | $1,661,000 | 0.14% |
| QVT Financial LP | 363,292 | $3,549,000 | 0.12% |
| Kinsight, LLC | 10,053 | $98,000 | 0.07% |
| Welch Group, LLC | 33,769 | $330,000 | 0.06% |
| Visium Asset Management, LP | 436,336 | $4,263,000 | 0.06% |
| Candriam S.C.A. | 135,300 | $1,322,000 | 0.03% |